FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018746638> ?p ?o ?g. }

• W2018746638 endingPage "106" @default.
• W2018746638 startingPage "99" @default.
• W2018746638 abstract "Sarcopenia, the age-related loss of muscle mass and function, represents a relevant public health issue due to its high prevalence and detrimental consequences. While the exact mechanisms underlying the pathogenesis of sarcopenia are not clear, growing experimental evidence indicates that progressive myonuclear elimination over the course of aging via an apoptosis-like process may represent a converging mechanism through which muscle atrophy and loss of physical function develop. Notably, the proapoptotic environment taking place in aged muscle appears amenable to interventions.We aimed at providing (1) an overview of signaling pathways of apoptosis relevant to sarcopenia, and (2) a review of the literature supporting myocyte apoptosis as a target for interventions against muscle aging.We summarized findings from studies focused on skeletal myocyte apoptosis as a mechanism in the development of sarcopenia and reports supporting myonuclear apoptosis as a target for interventions against age-related muscle loss.Advanced age is associated with increased signaling through extrinsic and intrinsic apoptotic pathways in skeletal myocytes. In contrast, downregulation of myocyte apoptosis through calorie restriction, exercise training, hormonal supplementation, drugs (e.g. angiotensin-converting enzyme inhibitors, acetaminophen, antimyostatin antibodies), nutraceuticals or genetic interventions (e.g. PGC-1α overexpression) is linked with preservation of muscle integrity and improved physical performance in late life. Preliminary data also indicate that skeletal myocyte apoptotic signaling may be downregulated by compounds, such as resveratrol, with calorie restriction-mimicking properties. Whether exercise mimetics exert a similar effect has not yet been investigated.Available evidence suggests that targeting myonuclear apoptosis might provide novel and effective therapeutic tools to combat sarcopenia. Further research is required to definitely establish if downregulating myonuclear apoptosis is effective in maintaining muscle mass and function in late life, identify the most relevant apoptotic pathway(s) to target, and determine the optimal timing for intervening." @default.
• W2018746638 created "2016-06-24" @default.
• W2018746638 creator A5001960093 @default.
• W2018746638 creator A5028177578 @default.
• W2018746638 creator A5037200438 @default.
• W2018746638 creator A5049412879 @default.
• W2018746638 date "2011-09-23" @default.
• W2018746638 modified "2023-10-13" @default.
• W2018746638 title "Apoptosis in Skeletal Myocytes: A Potential Target for Interventions against Sarcopenia and Physical Frailty – A Mini-Review" @default.
• W2018746638 cites W1533492381 @default.
• W2018746638 cites W1966543415 @default.
• W2018746638 cites W1971214199 @default.
• W2018746638 cites W1979496891 @default.
• W2018746638 cites W1983415262 @default.
• W2018746638 cites W1983765321 @default.
• W2018746638 cites W1985139869 @default.
• W2018746638 cites W1992930655 @default.
• W2018746638 cites W1992954113 @default.
• W2018746638 cites W1996034376 @default.
• W2018746638 cites W1999472449 @default.
• W2018746638 cites W2013873946 @default.
• W2018746638 cites W2021612469 @default.
• W2018746638 cites W2042533702 @default.
• W2018746638 cites W2047232246 @default.
• W2018746638 cites W2047293185 @default.
• W2018746638 cites W2049129011 @default.
• W2018746638 cites W2052853635 @default.
• W2018746638 cites W2053461708 @default.
• W2018746638 cites W2054506308 @default.
• W2018746638 cites W2054853648 @default.
• W2018746638 cites W2055907651 @default.
• W2018746638 cites W2061075485 @default.
• W2018746638 cites W2077103753 @default.
• W2018746638 cites W2087330696 @default.
• W2018746638 cites W2097173670 @default.
• W2018746638 cites W2099385136 @default.
• W2018746638 cites W2102902846 @default.
• W2018746638 cites W2106005889 @default.
• W2018746638 cites W2119800239 @default.
• W2018746638 cites W2138090131 @default.
• W2018746638 cites W2149386057 @default.
• W2018746638 cites W2154584639 @default.
• W2018746638 cites W2158403964 @default.
• W2018746638 cites W2171217650 @default.
• W2018746638 cites W2334583744 @default.
• W2018746638 doi "https://doi.org/10.1159/000330064" @default.
• W2018746638 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7077073" @default.
• W2018746638 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21952604" @default.
• W2018746638 hasPublicationYear "2011" @default.
• W2018746638 type Work @default.
• W2018746638 sameAs 2018746638 @default.
• W2018746638 citedByCount "121" @default.
• W2018746638 countsByYear W20187466382012 @default.
• W2018746638 countsByYear W20187466382013 @default.
• W2018746638 countsByYear W20187466382014 @default.
• W2018746638 countsByYear W20187466382015 @default.
• W2018746638 countsByYear W20187466382016 @default.
• W2018746638 countsByYear W20187466382017 @default.
• W2018746638 countsByYear W20187466382018 @default.
• W2018746638 countsByYear W20187466382019 @default.
• W2018746638 countsByYear W20187466382020 @default.
• W2018746638 countsByYear W20187466382021 @default.
• W2018746638 countsByYear W20187466382022 @default.
• W2018746638 countsByYear W20187466382023 @default.
• W2018746638 crossrefType "journal-article" @default.
• W2018746638 hasAuthorship W2018746638A5001960093 @default.
• W2018746638 hasAuthorship W2018746638A5028177578 @default.
• W2018746638 hasAuthorship W2018746638A5037200438 @default.
• W2018746638 hasAuthorship W2018746638A5049412879 @default.
• W2018746638 hasBestOaLocation W20187466381 @default.
• W2018746638 hasConcept C134018914 @default.
• W2018746638 hasConcept C190283241 @default.
• W2018746638 hasConcept C207200792 @default.
• W2018746638 hasConcept C2776214593 @default.
• W2018746638 hasConcept C2776263037 @default.
• W2018746638 hasConcept C2778707264 @default.
• W2018746638 hasConcept C2779959927 @default.
• W2018746638 hasConcept C3763915 @default.
• W2018746638 hasConcept C55493867 @default.
• W2018746638 hasConcept C60644358 @default.
• W2018746638 hasConcept C71924100 @default.
• W2018746638 hasConcept C86803240 @default.
• W2018746638 hasConceptScore W2018746638C134018914 @default.
• W2018746638 hasConceptScore W2018746638C190283241 @default.
• W2018746638 hasConceptScore W2018746638C207200792 @default.
• W2018746638 hasConceptScore W2018746638C2776214593 @default.
• W2018746638 hasConceptScore W2018746638C2776263037 @default.
• W2018746638 hasConceptScore W2018746638C2778707264 @default.
• W2018746638 hasConceptScore W2018746638C2779959927 @default.
• W2018746638 hasConceptScore W2018746638C3763915 @default.
• W2018746638 hasConceptScore W2018746638C55493867 @default.
• W2018746638 hasConceptScore W2018746638C60644358 @default.
• W2018746638 hasConceptScore W2018746638C71924100 @default.
• W2018746638 hasConceptScore W2018746638C86803240 @default.
• W2018746638 hasIssue "2" @default.
• W2018746638 hasLocation W20187466381 @default.
• W2018746638 hasLocation W20187466382 @default.
• W2018746638 hasLocation W20187466383 @default.

• next